Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 59.00 | |
2 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 120.00 | |
10 mg | In stock | $ 198.00 | |
25 mg | In stock | $ 379.00 | |
50 mg | In stock | $ 563.00 | |
100 mg | In stock | $ 792.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 132.00 |
Description | Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy. |
Targets&IC50 | NNRT:119 nM (IC50) |
Synonyms | Lersivirine(UK 453061), UK-453061 |
Molecular Weight | 310.35 |
Formula | C17H18N4O2 |
CAS No. | 473921-12-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (161.11 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lersivirine 473921-12-9 Microbiology/Virology Proteases/Proteasome HIV Protease Reverse Transcriptase HIV non-nucleoside reverse transcription HIV virus Inhibitor UK 453061 Human immunodeficiency virus Lersivirine(UK 453061) inhibit UK453061 UK-453061 resistant strain NNRTI NNRTI-resistant inhibitor